Sign up to save your podcasts
Or
Share 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.9
5656 ratings
Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
JAMA Editors' Summary
142 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
499 Listeners
Breast Cancer Update
67 Listeners
Lung Cancer Update
32 Listeners
Hematologic Oncology Update
75 Listeners
Prostate Cancer Update
15 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
13 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
118 Listeners
ASCO Daily News
58 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
The ONS Podcast
198 Listeners
ASCO Guidelines
43 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Two Onc Docs
190 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
41 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners